Recipharm has established a holding company for its biologics development facilities in Sweden and the UK. The shareholders in the new company, Cobra Biologics Holding which will continue to trade as RecipharmCobra Biologics, are its management team, Zentricity Holding and Recipharm. Recipharm has decided to concentrate on its core business activities.
Recipharm
Tuesday 5 July 2011
Recipharm spins out biologics facilities
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment